Dane Andreeff, Director at HELIUS MEDICAL TECHNOLOGIES, INC. (HSDT), bought 10,000 shares at $10.10 ($101K) on 2018-06-25, disclosed to the SEC on 2018-06-27.
Open-market purchase of $101k HSDT by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.10 | 609 | $6K | 6.1% |
| 2 | $10.10 | 1,634 | $17K | 16.3% |
| 3 | $10.10 | 2,757 | $28K | 27.6% |
| 4 | $10.10 | 304 | $3K | 3.0% |
| 5 | $10.10 | 817 | $8K | 8.2% |
| 6 | $10.10 | 1,379 |
| $14K |
| 13.8% |
| 7 | $10.11 | 304 | $3K | 3.0% |
| 8 | $10.11 | 817 | $8K | 8.2% |
| 9 | $10.11 | 1,379 | $14K | 13.8% |
| Total | $10.10 avg | 10,000 | $101K | 100% |
| Filing → |
| HSDT | BUY | 2023-08-30 | $71K | — | Filing → |
| HSDT | BUY | 2022-12-19 | $20K | — | Filing → |
| HSDT | BUY | 2022-11-25 | $29K | — | Filing → |